文献速递认知障碍与痴呆

原发性进行性失语伴阿尔茨海默病理的皮层胆碱能去神经支配

Cortical cholinergic denervation in primary progressive aphasia with Alzheimer pathology.
PubMed 文献 · Neurology · 2019-03-06

该研究对36例原发性进行性失语(PPA)患者脑组织进行基底前脑胆碱能神经元(BFCN)半定量评级,并对5例PPA-AD和7例对照进行详细病理与立体学分析。结果显示约80%的PPA-AD存在中重度BFCN丢失和胶质增生,而PPA-tau和PPA-TDP中罕见;PPA-AD还出现皮层胆碱能轴突丢失,以左半球语言相关皮层更严重。结论提示伴有AD生物标志物阳性的PPA患者可从胆碱能治疗中获益。

要点

  • PPA-AD患者中约80%存在中重度基底前脑胆碱能神经元丢失和胶质增生。
  • PPA-tau和PPA-TDP患者中基底前脑胆碱能神经元丢失罕见。
  • PPA-AD患者皮层胆碱能轴突丢失以左半球语言相关皮层更严重。

核心结论

  • PPA-AD患者存在显著的基底前脑胆碱能神经元和皮层胆碱能轴突丢失,而其他神经病理亚型PPA中罕见。
  • 胆碱能去神经支配的解剖分布与临床失语表现相符,支持对AD生物标志物阳性的PPA患者进行胆碱能治疗。

研究设计与样本

  • 研究纳入36例PPA患者脑组织,其中PPA-AD 14例,PPA-tau 12例,PPA-TDP 10例,进行基底前脑胆碱能神经元变性和胶质增生的半定量评级。
  • 对5例PPA-AD和7例对照脑组织进行免疫组化和组织化学及立体学分析,详细评估BFCN病理和皮层胆碱能轴突丢失。

主要发现

  • 半定量评级显示11例(约80%)PPA-AD患者存在中重度BFCN丢失和胶质增生,而PPA-tau中无此类评级,PPA-TDP中仅1例(10%)有此类评级。
  • 详细分析显示PPA-AD患者存在大量神经原纤维缠结形成、BFCN丢失和皮层胆碱能轴突变性。
  • 与对照组相比,PPA-AD患者p75低亲和力神经营养因子受体阳性BFCN丢失(p < 0.01)。
  • 所有研究皮层区域的乙酰胆碱酯酶阳性胆碱能轴突在PPA-AD中均显示丢失(p < 0.005-0.0001)。
  • 丢失在语言优势的左半球更严重,且在左半球内以语言相关皮层区域更显著。

临床怎么用

  • 对于AD生物标志物阳性的PPA患者,可考虑胆碱能治疗。
  • PPA患者应进行AD生物标志物检测以指导治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the status of the basal forebrain cholinergic system in primary progressive aphasia (PPA) as justification for cholinergic therapy. METHODS: A cohort of 36 brains from PPA participants with the neuropathology of Alzheimer disease (PPA-AD, n = 14) or frontotemporal lobar degeneration (PPA-tau, n = 12; PPA-TDP, n = 10) were used for semiquantitative rating of degeneration and gliosis of basal forebrain cholinergic neurons (BFCN). A subpopulation of 5 PPA-AD and 7 control brains underwent detailed analysis of BFCN pathology and cortical cholinergic axonal loss employing immunohistochemical and histochemical methods and stereologic analysis. RESULTS: Semiquantitatively, 11 (∼80%) PPA-AD participants were rated as having moderate/severe BFCN loss and gliosis, whereas none of the PPA-tau and only 1 (10%) PPA-TDP participant received such a rating. Detailed analysis in the subpopulation of PPA-AD participants revealed substantial tangle formation, loss of BFCN, and degeneration of cortical cholinergic axons. Compared to controls, loss of p75 low affinity neurotrophin receptor-positive BFCN was detected in the PPA-AD participants (p < 0.01). Acetylcholinesterase-positive cholinergic axons in all cortical areas studied displayed loss in PPA-AD (p < 0.005-0.0001). The loss was more severe in the language-dominant left hemisphere and, within the left hemisphere, in language-affiliated cortical areas. CONCLUSIONS: Our results demonstrate prominent depletion of BFCN and cortical cholinergic axons in PPA-AD when compared with normal control or other neuropathologic variants of PPA. The demonstration of cholinergic denervation with an anatomy that fits the clinical picture suggests that cholinergic treatment is justified in patients with PPA who have positive AD biomarkers.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mesulam MM, Lalehzari N, Rahmani F, et al. Cortical cholinergic denervation in primary progressive aphasia with Alzheimer pathology. Neurology. 2019. PMID: 30842294. doi:10.1212/WNL.0000000000007247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。